ACP5 and osteoporosis: Overall, these results demonstrate that puerarin reduces bone loss in the OVX-induced osteoporosis mice by suppressing the proliferation of TRAcP-positive osteoclasts and inhibiting the bone resorption activity of the osteoclasts.